Show simple item record

dc.contributor.authorTruong, Dawn
dc.contributor.authorMarsh, Wendy K.
dc.date2022-08-11T08:10:31.000
dc.date.accessioned2022-08-23T17:11:46Z
dc.date.available2022-08-23T17:11:46Z
dc.date.issued2019-11-25
dc.date.submitted2020-01-02
dc.identifier.citation<p>Curr Psychiatry Rep. 2019 Nov 25;21(12):130. doi: 10.1007/s11920-019-1111-3. <a href="https://doi.org/10.1007/s11920-019-1111-3">Link to article on publisher's site</a></p>
dc.identifier.issn1523-3812 (Linking)
dc.identifier.doi10.1007/s11920-019-1111-3
dc.identifier.pmid31768664
dc.identifier.urihttp://hdl.handle.net/20.500.14038/46357
dc.description.abstractPURPOSE OF REVIEW: We review recent data on bipolar disorder in menopausal-aged women, particularly in women undergoing the menopausal transition (MT). We discuss evidence on the severity of symptoms in bipolar women during the MT. Moreover, we address two factors in bipolar disorder and menopausal research: standardized menopausal staging and women's conceptualization of their menopausal and bipolar symptoms. RECENT FINDINGS: While there are few studies within the last 5 years on bipolar women undergoing the MT, new evidence suggest that mood symptoms in women worsen with progression through the MT. Consistent use of the standardized menopausal staging system can facilitate understanding of the timing of worsening symptoms. Moreover, whether women conceptualize their symptoms as arising from their MT or bipolar disorder can influence whether they seek hormonal therapy or psychiatric treatment, respectively. The MT is a potential time for mood instability in vulnerable women, which can manifest as first-onset development of bipolar disorder or increased symptom severity in women with pre-existing bipolar disorder. Adoption of a standardized menopausal staging may offer novel frameworks for understanding of the role of the MT in bipolar disorder.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=31768664&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1007/s11920-019-1111-3
dc.subjectBipolar disorder
dc.subjectHormonal fluctuations
dc.subjectMenopausal staging
dc.subjectMenopausal transition
dc.subjectMood
dc.subjectPerimenopause
dc.subjectHormones, Hormone Substitutes, and Hormone Antagonists
dc.subjectPsychiatry
dc.subjectPsychiatry and Psychology
dc.subjectPsychological Phenomena and Processes
dc.subjectReproductive and Urinary Physiology
dc.subjectWomen's Health
dc.titleBipolar Disorder in the Menopausal Transition
dc.typeJournal Article
dc.source.journaltitleCurrent psychiatry reports
dc.source.volume21
dc.source.issue12
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/psych_pp/918
dc.identifier.contextkey16101318
html.description.abstract<p>PURPOSE OF REVIEW: We review recent data on bipolar disorder in menopausal-aged women, particularly in women undergoing the menopausal transition (MT). We discuss evidence on the severity of symptoms in bipolar women during the MT. Moreover, we address two factors in bipolar disorder and menopausal research: standardized menopausal staging and women's conceptualization of their menopausal and bipolar symptoms.</p> <p>RECENT FINDINGS: While there are few studies within the last 5 years on bipolar women undergoing the MT, new evidence suggest that mood symptoms in women worsen with progression through the MT. Consistent use of the standardized menopausal staging system can facilitate understanding of the timing of worsening symptoms. Moreover, whether women conceptualize their symptoms as arising from their MT or bipolar disorder can influence whether they seek hormonal therapy or psychiatric treatment, respectively. The MT is a potential time for mood instability in vulnerable women, which can manifest as first-onset development of bipolar disorder or increased symptom severity in women with pre-existing bipolar disorder. Adoption of a standardized menopausal staging may offer novel frameworks for understanding of the role of the MT in bipolar disorder.</p>
dc.identifier.submissionpathpsych_pp/918
dc.contributor.departmentSchool of Medicine
dc.contributor.departmentDepartment of Psychiatry
dc.source.pages130


This item appears in the following Collection(s)

Show simple item record